iShares Biotechnology ETF(IBB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

IBB iShares Biotechnology ETF

Pre-Mkt 07-15 08:33:48 EDT

188.67

-0.88

-0.46%

盘前188.38

-0.29-0.16%

08:23 EDT

High189.74	Low187.56	Vol1.21M
Open189.55	D1 Closing189.55	Amplitude1.15%
Mkt Cap9.21B	Tradable Cap9.21B	Total Shares48.80M
T/O227.79M	T/O Rate2.47%	Tradable Shares48.80M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"IBB","market":"US","secType":"STK","nameCN":"iShares Biotechnology ETF","latestPrice":188.67,"timestamp":1784059200000,"preClose":189.55,"halted":0,"volume":1206633,"hourTrading":{"tag":"盘前","latestPrice":188.3758,"preClose":188.67,"latestTime":"08:23 EDT","volume":1916,"amount":363143.50360000005,"timestamp":1784118210782,"change":-0.2942,"changeRate":-0.001559,"amplitude":0.004134},"delay":0,"changeRate":-0.004642574518596802,"floatShares":48800000,"shares":48800000,"eps":6.311863,"marketStatus":"Pre-Mkt","change":-0.88,"latestTime":"07-15 08:33:48 EDT","open":189.55,"high":189.74,"low":187.56,"amount":227785124.95850998,"amplitude":0.011501,"askPrice":189,"askSize":100,"bidPrice":188.2,"bidSize":9,"shortable":3,"etf":1,"ttmEps":6.311863,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1784122200000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":188.67,"sharesOutstanding":49450000,"nav":189.560469,"aum":9354809145.15,"dividendRate":0.0022,"bidAskSpread":0.000326,"preHourTrading":{"tag":"盘前","latestPrice":188.3758,"preClose":188.67,"latestTime":"08:23 EDT","volume":1916,"amount":363143.50360000005,"timestamp":1784118210782,"change":-0.2942,"changeRate":-0.001559,"amplitude":0.004134},"postHourTrading":{"tag":"盘后","latestPrice":188.65,"preClose":188.67,"latestTime":"19:56 EDT","volume":18817,"amount":3545632.8103,"timestamp":1784073414035,"change":-0.02,"changeRate":-0.000106,"amplitude":0.002173},"volumeRatio":0.5552711629178063,"impliedVol":0.1981,"impliedVolPercentile":0.164},"requestUrl":"/m/hq/s/IBB","defaultTab":"news","newsList":[{"id":"2651646874","title":"Ernexa Therapeutics announces new ERNA-101 preclinical data","url":"https://stock-news.laohu8.com/highlight/detail?id=2651646874","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651646874?lang=en_us&edition=fundamental","pubTime":"2026-07-15 20:15","pubTimestamp":1784117721,"startTime":"0","endTime":"0","summary":"Ernexa Therapeutics (ERNA) announced new preclinical data independently validating the anti-tumor activity of its lead cell therapy candidate, ERNA...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ernexa-therapeutics-announces-new-erna-101-preclinical-data-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ernexa-therapeutics-announces-new-erna-101-preclinical-data-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LFSC","SYNB","ERNA","IBBQ","BK4139","IBB","CNCR","BK4585","GNOM","FBT","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651450871","title":"BriaCell Arranges Scalable Manufacturing with FUJIFILM Biotechnologies for Bria-IMT™","url":"https://stock-news.laohu8.com/highlight/detail?id=2651450871","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651450871?lang=en_us&edition=fundamental","pubTime":"2026-07-15 19:30","pubTimestamp":1784115000,"startTime":"0","endTime":"0","summary":"Arrangement with FUJIFILM Biotechnologies California provides manufacturing capacity for the remainder of BriaCell’s pivotal Phase 3 study and commercial scalability potentialBria-IMT is currently bei","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/15/3327609/0/en/BriaCell-Arranges-Scalable-Manufacturing-with-FUJIFILM-Biotechnologies-for-Bria-IMT.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SYNB","BK4585","BK4139","CDMO","EES","BCTX","BK4588","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651715457","title":"Crinetics Pharmaceuticals (CRNX) Looks Fully Valued As Vertex Agrees $85 Per Share Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2651715457","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651715457?lang=en_us&edition=fundamental","pubTime":"2026-07-15 18:33","pubTimestamp":1784111595,"startTime":"0","endTime":"0","summary":"Vertex acquisition terms and what they mean for Crinetics shareholders\nCrinetics Pharmaceuticals (CRNX) stock is in focus after Vertex Pharmaceuticals agreed to acquire the company in a cash deal valuing Crinetics at about $10b, or $85 per share.\nThe transaction, announced on July 6, 2026, would make Crinetics a wholly owned subsidiary of Vertex if it closes. The financing would be supported by a mix of cash, debt, and committed bridge funding.\nSee our latest analysis for Crinetics...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-crnx/crinetics-pharmaceuticals/news/crinetics-pharmaceuticals-crnx-looks-fully-valued-as-vertex","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-crnx/crinetics-pharmaceuticals/news/crinetics-pharmaceuticals-crnx-looks-fully-valued-as-vertex","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE0009355771.USD","LU1778281490.HKD","VERX","LU2362541513.USD","LU0417517546.SGD","IDNA","LU0889565916.HKD","IE0002270589.USD","LU2456880835.USD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","IE00BZ9MQY76.HKD","LU1035775433.USD","IE0002141913.USD","LU1093756168.USD","IE00BJT1NW94.SGD","LU2362540622.SGD","PBE","LU2237438978.USD","BIB","LU2236285917.USD","BK4567","IE00B19Z9Z06.USD","SG9999001176.USD","BK4007","BK4532","LU0109394709.USD","BK4023","LU1674673428.USD","IBB","BK4139","LU0061475181.USD","LU0320765992.SGD","VRTX","LU0058720904.USD","LU2324357040.USD","LU1093756325.SGD","LU1815336091.USD","LU2362541273.HKD","BBH","IE00B19Z3581.USD","LU0757428866.USD","LU1069344957.HKD","IE00BFTCPJ56.SGD","CRNX","LU2417539215.USD","IBBQ","LU2462157665.USD","LU1430594728.SGD","LU1585245621.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651436224","title":"African Markets - Factors to Watch on July 15","url":"https://stock-news.laohu8.com/highlight/detail?id=2651436224","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651436224?lang=en_us&edition=fundamental","pubTime":"2026-07-15 12:00","pubTimestamp":1784088041,"startTime":"0","endTime":"0","summary":"African Markets - Factors to watch on July 15NAIROBI, July 15 (Reuters)-The following company announcements, scheduled economic indicators, debt and currency market moves and political events may affe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nL8N43H03H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","LU0289739699.SGD","IE00B19Z3581.USD","LU1674673428.USD","BK4578","BK4588","LU1778281490.HKD","IE00B19Z3B42.SGD","IBBQ","LU0882574055.USD","LU0965509283.SGD","LU0965508806.USD","LU0889565916.HKD","IE00BZ1G4Q59.USD","LU2324357040.USD","BK4139","LU0861579265.USD","IE00B7SZLL34.SGD","LU1839511570.USD","LU1934455277.USD","SG9999015952.SGD","LU0965509101.SGD","LU0114720955.EUR","BIB","LU1585245621.USD","IE0002270589.USD","BK4568","SG9999015945.SGD","LU0109394709.USD","LU0234570918.USD","LU2087621335.USD","SG9999015986.USD","BMED","BK4583","IBB","BK4550","IE00BKVL7J92.USD","SG9999015978.USD","LU1571399168.USD","BK4585","LU2112291526.USD","LU1674673691.USD","LU0122379950.USD","LU1057294990.SGD","MEDI","LU1066053197.SGD","IE00BSNM7G36.USD","IE00B3T34201.USD","GILD","LU1934455194.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651484502","title":"Regeneron’s dupilumab granted orphan drug designation","url":"https://stock-news.laohu8.com/highlight/detail?id=2651484502","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651484502?lang=en_us&edition=fundamental","pubTime":"2026-07-15 05:05","pubTimestamp":1784063112,"startTime":"0","endTime":"0","summary":"Regeneron’s (REGN) dupilumab was granted FDA orphan drug designation, according to a post on the agency’s website. Published first on TheFly – the ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regenerons-dupilumab-granted-orphan-drug-designation-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regenerons-dupilumab-granted-orphan-drug-designation-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0882574055.USD","LU2023250504.SGD","LU2362541273.HKD","LU0823434583.USD","LU1917777945.USD","LU2362540622.SGD","BBP","LU0823434740.USD","BK4139","IBB","BBH","BK4588","BK4585","LU1974910355.USD","IBBQ","LU0889565916.HKD","LU2089984988.USD","LABU","LU0109394709.USD","LU2468319806.SGD","LU0320765992.SGD","LU0114720955.EUR","LU2362541513.USD","LU0053666078.USD","LU2237438978.USD","LU0289739699.SGD","LU0823416689.USD","LU0058720904.USD","LU2106854487.HKD","REGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651655484","title":"Celcuity announces FDA approval of Revtorpyk","url":"https://stock-news.laohu8.com/highlight/detail?id=2651655484","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651655484?lang=en_us&edition=fundamental","pubTime":"2026-07-15 04:55","pubTimestamp":1784062511,"startTime":"0","endTime":"0","summary":"Celcuity (CELC) announced that the U.S. Food and Drug Administration approved REVTORPYK for the treatment of patients with hormone receptor positiv...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/celcuity-announces-fda-approval-of-revtorpyk-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/celcuity-announces-fda-approval-of-revtorpyk-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSCH","MRNX","IDNA","RSPH","LFSC","LABU","FRTY","CELC","MRNY","BK4585","BK4139","SYNB","BMED","TECB","GDOC","IYH","IBB","BBP","PINK","MEDI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651048909","title":"Amgen Inc. Stock Outperforms Competitors Despite Losses on the Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2651048909","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651048909?lang=en_us&edition=fundamental","pubTime":"2026-07-15 04:34","pubTimestamp":1784061240,"startTime":"0","endTime":"0","summary":"DJ Amgen Inc. Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  shed 1.44% to $355.25 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.38% to 7,543.59 and the Dow Jones Industrial Average  rising 0.02% to 52,508.27.This was the stock's fifth consecutive day of losses.Amgen Inc. closed 9.21% short of its 52-week high of $391.29, which the company achieved on March 2nd.The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson  fell 1.52% to $253.85, Pfizer Inc.  fell 0.94% to $24.25, and AbbVie Inc.  fell 1.30% to $244.78.Trading volume  remained 1.3 million below its 50-day average volume of 2.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled July 14, 2026.This content was created by MarketWatch, which is operated by Dow J","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","LU1023059063.AUD","LU2242646821.SGD","LU2112291526.USD","LU0122379950.USD","LU0889565916.HKD","LU2468319806.SGD","BK4566","IE00B4R5TH58.HKD","IE00B2B36J28.USD","PJP","BK4588","LU1983299246.USD","IE0002141913.USD","IE00BJT1NW94.SGD","LU1057294990.SGD","PBE","BK4581","BIB","LU0109394709.USD","BK4534","SG9999001440.SGD","LU2089984988.USD","IBB","BK4139","LU0320765992.SGD","LU1061106388.HKD","LU0058720904.USD","LU1571399168.USD","IE00BJJMRZ35.SGD","LU0868494617.USD","AMGN","BBH","LU0289739699.SGD","IE00BFTCPJ56.SGD","BK4585","BK4533","LU2242652126.USD","IBBQ","04332","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651060081","title":"Sector Update: Healthcare Stocks Mixed Premarket Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2651060081","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651060081?lang=en_us&edition=fundamental","pubTime":"2026-07-14 21:15","pubTimestamp":1784034940,"startTime":"0","endTime":"0","summary":"Healthcare stocks were mixed premarket Tuesday, with the State Street Health Care Select Sector SPDR ETF  down 0.3% and the iShares Biotechnology ETF  0.1% higher.HCA Healthcare  shares were down more than 9% after the company cut its 2026 adjusted diluted EPS guidance.NextCure  will merge with privately held Avere Therapeutics in an all-stock transaction to advance Avere's lead oral IL-23 therapy, AVR-001, for inflammatory diseases, the company said. NextCure shares were surging past 313% pre-bell.Spero Therapeutics  has licensed exclusive worldwide rights, excluding Greater China, to develop and commercialize Innovent Biologics' immunology drug candidate, IBI355, under a deal valued at up to about $1.1 billion, the companies said. Spero Therapeutics stock was up 0.5% premarket.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","IHF","LU2244417387.USD","LU0029874061.USD","LU1201861249.SGD","LU0878866978.SGD","SPRO","HCA","XBI","LU0029864427.USD","BK4588","SG9999014005.SGD","LU0203345920.USD","LU1150488218.USD","IE00B3S45H60.SGD","BK4581","LU0310800379.SGD","LU1084165304.USD","BK4585","LU0187121727.USD","LU1150488135.SGD","IBB","LU1267930573.SGD","LU0310799852.SGD","LU1489326972.SGD","HCSG","LU1261432733.SGD","LU0114720955.EUR","LU1267930490.SGD","LU0211327993.USD","LU1119994496.HKD","NXTC","XLV","BK4504","LU0128526141.USD","LU0068578508.USD","LU0882574055.USD","LU0648001328.SGD","BK4137","BK4185","LU0980610538.SGD","SG9999014021.USD","LABU","LU0211328371.USD","LU0433182093.SGD","LU0203347892.USD","LU0128525929.USD","LU0868494617.USD","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651106449","title":"Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Tuesday Ahead of Warsh Testimony","url":"https://stock-news.laohu8.com/highlight/detail?id=2651106449","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651106449?lang=en_us&edition=fundamental","pubTime":"2026-07-14 21:04","pubTimestamp":1784034260,"startTime":"0","endTime":"0","summary":"The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.3%, and the actively traded Invesco QQQ Trust (QQQ) advanced 1.1% in Tuesday's premarket activity, ahead of Federal Reserve ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HCA","QQQ","FAS","PMR","SPY","UNG","EQR","VHT.AU","XLI","XSD","EXI","IBB","BP","GLD","FDN","EETH","RTH","XLV","VIS","USO","IBM","IGM","EEM","RTH.AU","XLY","GFUZ","BITO","XLE","XLF","XLK","IGV","IVV","BETH","IYW","IYK","XRT","FAZ","IYJ","XLP","SOXX","VHT","IYE","VDC","IWM","SLV","IYH","SPY.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651105065","title":"Congo Begins Trial of Gilead's Experimental Antiviral for Ebola Bundibugyo","url":"https://stock-news.laohu8.com/highlight/detail?id=2651105065","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651105065?lang=en_us&edition=fundamental","pubTime":"2026-07-14 20:46","pubTimestamp":1784033215,"startTime":"0","endTime":"0","summary":"Congo begins trial of Gilead's experimental antiviral for Ebola BundibugyoJuly 14 (Reuters)-Researchers in the Democratic Republic of Congo said on Tuesday they have started enrolling participants in ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nL4N43G15P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3T34201.USD","BK4550","LU0320765992.SGD","LU1571399168.USD","LU2324357040.USD","SG9999015978.USD","SG9999015986.USD","LU1934455277.USD","BK4588","LU1037948897.HKD","LU2112291526.USD","BBH","SG9999015952.SGD","IE00B19Z3581.USD","IE00BKVL7J92.USD","LU1066053197.SGD","LU0889565916.HKD","BIB","IE0002270589.USD","LU0861579265.USD","LU1674673428.USD","BMED","GILD","IE00B7SZLL34.SGD","IBBQ","MEDI","IBB","IE00B19Z3B42.SGD","LU0882574055.USD","LU1061106388.HKD","LU0965509283.SGD","LU0289739699.SGD","LU2468319806.SGD","LU0965509010.AUD","LU1057294990.SGD","LU0122379950.USD","LU0109394709.USD","BK4578","LU2087621335.USD","LU1066051498.USD","LU1585245621.USD","LU1839511570.USD","LU1430594728.SGD","IE00BZ1G4Q59.USD","LU1778281490.HKD","LU1934455194.USD","BK4532","LU1037948541.HKD","LU0234570918.USD","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651105407","title":"Caris Life Sciences expands prostate cancer offering with PTEN IHC testing","url":"https://stock-news.laohu8.com/highlight/detail?id=2651105407","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651105407?lang=en_us&edition=fundamental","pubTime":"2026-07-14 20:35","pubTimestamp":1784032510,"startTime":"0","endTime":"0","summary":"Caris Life Sciences (CAI) will offer in-house PTEN immunohistochemistry, or IHC, testing following the recent FDA approval of a biomarker-guided th...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/caris-life-sciences-expands-prostate-cancer-offering-with-pten-ihc-testing-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/caris-life-sciences-expands-prostate-cancer-offering-with-pten-ihc-testing-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4092","BMED","BK4104","CAI","RSPH","FRTY","IYH","BK4588","GDOC","LFSC","PTEN","LABU","BK4162","PINK","BBP","MRNX","IHC","SYNB","MEDI","IDNA","BK4585","BK4139","MRNY","IBB","PSCH","TECB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651175813","title":"Sino Biopharmaceutical Stock Slips 1.0% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2651175813","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651175813?lang=en_us&edition=fundamental","pubTime":"2026-07-14 16:33","pubTimestamp":1784017980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. slid 1.0% to 5.11 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.5% to 24340.73.This was the stock's second consecutive day of losses.Sino Biopharmaceutical Ltd. closed 44% short of its 52-week high of HK$9.12, which the company reached Sept. 10.The stock underperformed when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 0.6% and Amgen Inc. remained unchanged.Trading volume totaled 131.1 million shares, compared to the 50-day average of 96.0 million shares.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJuly 14, 2026 04:33 ET Copyright  2026 Dow Jones & Company, Inc.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0122379950.USD","LU1571399168.USD","LU0058720904.USD","IE0009355771.USD","01177","BK1521","IE00BZ08YS42.EUR","BK1515","IBBQ","BK4533","LU2468319806.SGD","LU1983299246.USD","BK4599","BK4566","HK0000165453.HKD","LU0289739699.SGD","IE00B2B36J28.USD","LU1057294990.SGD","LU2089984988.USD","LU2242652126.USD","BIB","IE00BZ08YT58.USD","BK4534","LU2242646821.SGD","SG9999001440.SGD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","IE0002141913.USD","BK4581","IE00B4R5TH58.HKD","PBE","BK4588","LU0889565916.HKD","LU2112291526.USD","IE00BFTCPJ56.SGD","BK1191","IBB","LU1023059063.AUD","BK4585","LU0868494617.USD","LU0109394709.USD","BBH","LU1061106388.HKD","BK4139","IE00BZ08YR35.GBP","LU0320765992.SGD","AMGN","PJP","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651612476","title":"Nexalis Therapeutics Options Expire Unexercised, Streamlining Capital Structure","url":"https://stock-news.laohu8.com/highlight/detail?id=2651612476","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651612476?lang=en_us&edition=fundamental","pubTime":"2026-07-14 13:27","pubTimestamp":1784006857,"startTime":"0","endTime":"0","summary":"InhaleRx Limited ( ($AU:NX1) ) just unveiled an announcement. Nexalis Therapeutics Ltd, an ASX-listed biotechnology company trading under the ticke...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nexalis-therapeutics-options-expire-unexercised-streamlining-capital-structure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nexalis-therapeutics-options-expire-unexercised-streamlining-capital-structure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","SYNB","BK4585","FWD","BK4139","BK4539","RSPH","AGNG","JDOC","DARP","XT","LENZ","BK4007","BBP","IBB","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651247371","title":"Nexalis Therapeutics Issues Over 4.1 Million Unquoted Performance Rights","url":"https://stock-news.laohu8.com/highlight/detail?id=2651247371","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651247371?lang=en_us&edition=fundamental","pubTime":"2026-07-14 13:27","pubTimestamp":1784006835,"startTime":"0","endTime":"0","summary":"InhaleRx Limited ( ($AU:NX1) ) just unveiled an update. Nexalis Therapeutics Ltd is an Australian-listed biotechnology company focused on developin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nexalis-therapeutics-issues-over-4-1-million-unquoted-performance-rights?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nexalis-therapeutics-issues-over-4-1-million-unquoted-performance-rights?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4585","BK4539","XT","RSPH","IBB","SYNB","BK4588","FHLC","DARP","BK4139","LENZ","JDOC","AGNG","FWD","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651422771","title":"BioArctic’s Partner Eisai Wins FDA Nod for At-Home Leqembi Injection in Early Alzheimer’s","url":"https://stock-news.laohu8.com/highlight/detail?id=2651422771","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651422771?lang=en_us&edition=fundamental","pubTime":"2026-07-14 06:08","pubTimestamp":1783980525,"startTime":"0","endTime":"0","summary":"BioArctic AB Class B ( ($SE:BIOA.B) ) has shared an update. BioArctic’s partner Eisai has secured U.S. FDA approval for Leqembi Iqlik, a once-weekl...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bioarctics-partner-eisai-wins-fda-nod-for-at-home-leqembi-injection-in-early-alzheimers?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bioarctics-partner-eisai-wins-fda-nod-for-at-home-leqembi-injection-in-early-alzheimers?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0589944569.HKD","BK4585","PSCH","LU0516423174.USD","SG9999002414.USD","LU0441851309.USD","RSPH","BBP","SG9999014492.USD","GDOC","LU0516423091.SGD","LU0532188223.SGD","FDNI","IDNA","SYNB","TECB","BK4503","SG9999014484.SGD","BK4535","LU2360107671.USD","LU2065170008.USD","LABU","PINK","BK4554","IBB","LU2152927971.USD","LU0251143029.SGD","LU1861220207.SGD","SE","BK4220","HBCP","BK4211","LU2065171402.SGD","SG9999002679.SGD","LU0499858438.USD","SG9999002620.SGD","MRNY","BMED","LFSC","LU2125910849.SGD","MRNX","IYH","FRTY","SG9999013478.USD","LU0516422366.SGD","MEDI","IE0031814969.USD","BK4588","LU0823039010.USD","SG9999002406.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651144496","title":"Lakefront Biotherapeutics Board Member Resigns After Sanofi R&D Appointment","url":"https://stock-news.laohu8.com/highlight/detail?id=2651144496","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651144496?lang=en_us&edition=fundamental","pubTime":"2026-07-14 04:57","pubTimestamp":1783976270,"startTime":"0","endTime":"0","summary":"Lakefront Biotherapeutics ( ($LKFT) ) has provided an update. Lakefront Biotherapeutics, a Belgium-based biotechnology company listed on Euronext a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lakefront-biotherapeutics-board-member-resigns-after-sanofi-rd-appointment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lakefront-biotherapeutics-board-member-resigns-after-sanofi-rd-appointment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DARP","SNYNF","XT","RSPH","BBP","BK4007","SYNB","JDOC","IBB","AGNG","BK4585","FHLC","FWD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651814486","title":"Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2651814486","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651814486?lang=en_us&edition=fundamental","pubTime":"2026-07-14 04:35","pubTimestamp":1783974900,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  advanced 1.21% to $131.40 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 0.79% to 7,515.34 and Dow Jones Industrial Average  falling 0.26% to 52,498.64.The stock's rise snapped a three-day losing streak.Gilead Sciences Inc. closed 16.46% below its 52-week high of $157.29, which the company reached on February 11th.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson  rose 0.31% to $257.77, Pfizer Inc.  rose 1.28% to $24.48, and Abbott Laboratories  fell 1.94% to $92.11.Trading volume  remained 2.8 million below its 50-day average volume of 7.9 M.Data source: Dow Jones Market Data, FactSet. Data compiled July 13, 2026.This content was created by MarketWatc","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4585","IE00B19Z3581.USD","LU0965509010.AUD","LU0965508806.USD","LU1430594728.SGD","LU1674673428.USD","LU1934455194.USD","LU1934455277.USD","LU0109394709.USD","SG9999015952.SGD","LU1066053197.SGD","BK4532","LU0965509283.SGD","IE00B7SZLL34.SGD","SG9999015978.USD","BBH","IE00BKVL7J92.USD","LU2089984988.USD","LU2468319806.SGD","BK4139","LU1037948541.HKD","IBBQ","BK4588","LU0823416689.USD","LU1061106388.HKD","LU0234570918.USD","LU0058720904.USD","LU0882574055.USD","IE00B19Z3B42.SGD","LU1674673691.USD","GILD","IE00BZ1G4Q59.USD","LU0861579265.USD","LU2112291526.USD","MEDI","LU0965509101.SGD","BK4566","LU0289739699.SGD","IE00BSNM7G36.USD","LU1023059063.AUD","LU1066051498.USD","LU1571399168.USD","LU1585245621.USD","LU0114720955.EUR","LU1934455863.HKD","BMED","BK4583","LU0889565916.HKD","IE0002270589.USD","IBB","LU2324357040.USD","SG9999015986.USD","BIB","LU1839511570.USD","LU2087621335.USD","LU0122379950.USD","BK4578","LU0320765992.SGD","LU1778281490.HKD","LU1057294990.SGD","BK4550","SG9999015945.SGD","LU1037948897.HKD","IE00B3T34201.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651145087","title":"Voyager Therapeutics advances tau-silencing gene therapy program","url":"https://stock-news.laohu8.com/highlight/detail?id=2651145087","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651145087?lang=en_us&edition=fundamental","pubTime":"2026-07-14 01:27","pubTimestamp":1783963636,"startTime":"0","endTime":"0","summary":"Voyager Therapeutics ( ($VYGR) ) has provided an update. On July 13, 2026, Voyager Therapeutics presented three- and six-month good laboratory prac...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/voyager-therapeutics-advances-tau-silencing-gene-therapy-program?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/voyager-therapeutics-advances-tau-silencing-gene-therapy-program?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IBB","CNCR","LFSC","VYGR","FBT","BK4588","BK4585","GNOM","IBBQ","SYNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651112449","title":"Amgen Inc : UBS Raises Target Price to $420 from $400","url":"https://stock-news.laohu8.com/highlight/detail?id=2651112449","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651112449?lang=en_us&edition=fundamental","pubTime":"2026-07-13 21:50","pubTimestamp":1783950640,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nFWN43F0QW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4566","IE00B4R5TH58.HKD","LU0109394709.USD","IE00BJT1NW94.SGD","LU0889565916.HKD","LU0868494617.USD","LU0058720904.USD","IBBQ","LU0289739699.SGD","BK4585","LU2089984988.USD","IBB","IE00BFTCPJ56.SGD","LU2112291526.USD","SG9999001440.SGD","LU0122379950.USD","LU1057294990.SGD","BK4533","IE0009355771.USD","IE00B2B36J28.USD","LU2242646821.SGD","BK4139","BK4534","LU1061106388.HKD","AMGN","LU0320765992.SGD","BBH","LU1983299246.USD","BK4599","BK4588","LU2468319806.SGD","LU1023059063.AUD","PBE","IE0002141913.USD","PJP","IE00BJJMRZ35.SGD","BK4581","BIB","LU1571399168.USD","LU2242652126.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651114292","title":"Cue Biopharma Names Dominic Borie Chief Medical Officer, Head of R&D","url":"https://stock-news.laohu8.com/highlight/detail?id=2651114292","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651114292?lang=en_us&edition=fundamental","pubTime":"2026-07-13 21:17","pubTimestamp":1783948641,"startTime":"0","endTime":"0","summary":"Cue Biopharma names Dominic Borie chief medical officer, head of R&DCue Biopharma named Dominic Borie as chief medical officer, head of research and development, reporting to CEO Shao-Lee Lin.Borie wa","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nNDLb1kn5y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","SG9999014039.USD","LU2210150020.SGD","SG9999001440.SGD","LU2089984988.USD","LU1061106388.HKD","BK4566","LU2468319806.SGD","IE00BJT1NW94.SGD","KYTX","LU1023059063.AUD","LU0320765992.SGD","IBBQ","IE00BJJMRZ35.SGD","SG9999014021.USD","IE00B2B36J28.USD","IE00BGHQF748.EUR","NDAQ","LU0122379950.USD","BK4585","IE00B3QW5Z07.USD","LU0314104364.USD","BBH","BK4139","LU0868494617.USD","AMGN","PJP","IE00BN0W2W23.USD","BK4533","BIB","IE00B4R5TH58.HKD","CUE","IE00BN0W2T93.GBP","LU0058720904.USD","IE0002141913.USD","LU2242652126.USD","LU2242646821.SGD","BCDF","BK4112","LU2112291526.USD","LU0289739699.SGD","PBE","LU1057294990.SGD","LU2095319765.USD","LU0889565916.HKD","LU0109394709.USD","IE0009355771.USD","IBB","LU1983299246.USD","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0482},{"period":"1month","weight":0.1055},{"period":"3month","weight":0.072},{"period":"6month","weight":0.1062},{"period":"1year","weight":0.4305},{"period":"ytd","weight":0.1179}],"compareEarnings":[{"period":"1week","weight":0.0055},{"period":"1month","weight":0.0136},{"period":"3month","weight":0.0741},{"period":"6month","weight":0.0861},{"period":"1year","weight":0.2033},{"period":"ytd","weight":0.1025}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.","yearOnYearQuotes":[{"month":1,"riseRate":0.722222,"avgChangeRate":0.019108},{"month":2,"riseRate":0.611111,"avgChangeRate":-0.001245},{"month":3,"riseRate":0.555556,"avgChangeRate":0.002788},{"month":4,"riseRate":0.5,"avgChangeRate":0.003638},{"month":5,"riseRate":0.611111,"avgChangeRate":0.009102},{"month":6,"riseRate":0.777778,"avgChangeRate":0.027534},{"month":7,"riseRate":0.722222,"avgChangeRate":0.03631},{"month":8,"riseRate":0.470588,"avgChangeRate":-0.000694},{"month":9,"riseRate":0.411765,"avgChangeRate":-0.000938},{"month":10,"riseRate":0.388889,"avgChangeRate":-0.014563},{"month":11,"riseRate":0.833333,"avgChangeRate":0.040881},{"month":12,"riseRate":0.555556,"avgChangeRate":0.007272}],"exchange":"NASDAQ","name":"iShares Biotechnology ETF","nameEN":"iShares Biotechnology ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"iShares Biotechnology ETF(IBB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest iShares Biotechnology ETF(IBB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"iShares Biotechnology ETF,IBB,iShares Biotechnology ETF股票,iShares Biotechnology ETF股票老虎,iShares Biotechnology ETF股票老虎国际,iShares Biotechnology ETF行情,iShares Biotechnology ETF股票行情,iShares Biotechnology ETF股价,iShares Biotechnology ETF股市,iShares Biotechnology ETF股票价格,iShares Biotechnology ETF股票交易,iShares Biotechnology ETF股票购买,iShares Biotechnology ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"iShares Biotechnology ETF(IBB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest iShares Biotechnology ETF(IBB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}